|
Siemens’ Second Warning Letter This Summer Cites Complaint Handling
Siemens Healthcare Diagnostics has received its second FDA warning letter this summer, following an inspection of the company’s Newark, Del., plant.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives